Skip to content

Effect of oxycodone to general anesthesia patients's safety and degree of comfort during perioperative period undergoing laparoscope abdominal surgery

Effect of oxycodone to general anesthesia patients's safety and degree of comfort during perioperative period undergoing laparoscope abdominal surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16007775
Enrollment
Unknown
Registered
2016-01-15
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastoentric tumor

Interventions

oxycodone group:perioperative analgesia with oxycodone
sufentanil group:perioperative analgesia with sufentanil

Sponsors

Department of Anesthesiology, Changzheng Hospital, Second Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Approved by the hospital ethics committee, 100 cases of laparoscopic gastric cancer and colorectal cancer surgery were selected(surgery time 2-4h). Age between 18-65, ASA I-II.

Exclusion criteria

Exclusion criteria: Patient exclusion criteria: allergic to oxycodone or Other ingredients in the preparation of oxycodone; Patients with history of respiratory disease; A long history of smoking; There were upper respiratory tract infection in the last 2 weeks; use of hormones, bronchial dilation agent in the last 2 weeks; Patients with heart ,brain, liver and kidney disease; Morbidly obese patients; The history of mental and neurological diseases was diagnosed before operation; Long term use of diazepam or opioid drug.

Design outcomes

Primary

MeasureTime frame
blood pressure;emergence agitation;Level of sedation;The degree of pain;cough reflex;respiratory depression;blood glucose;the plasma cortisol concentration;TNF-a;IL-1ß;IL-6;IL-10;OPRM1 A118G gene polymorphism;CYP3A4 gene polymorphism;CYP3A5 gene polymorphism;

Countries

China

Contacts

Public ContactYuan Hongbin
jfjccyy@163.com+86 13795229316

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026